Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
ID: 338351Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/338351

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-22-114.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering Administrative Supplements to support new cancer disparities research through the National Cancer Institute (NCI). This funding opportunity aims to engage investigators who typically do not focus on cancer disparities and encourages collaborations between seasoned cancer researchers and those specializing in cancer disparities, with the goal of enhancing multidisciplinary research addressing adverse differences in cancer outcomes among racial/ethnic minorities and underserved populations. Eligible applicants must hold active NCI awards that do not currently address cancer disparities, with a budget limit of $150,000 for a maximum of two years to expand existing projects. Interested parties can find more information and application details at the provided link, with the application deadline set for January 23, 2025.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    PAR-22-114.html
    The Department of Health and Human Services, through the National Cancer Institute (NCI), is offering Administrative Supplements to support new cancer disparities research. This funding opportunity aims to engage investigators who typically do not focus on cancer disparities and encourage collaborations between seasoned cancer researchers and those specializing in cancer disparities. The goal is to enhance multidisciplinary research addressing adverse differences in cancer outcomes among racial/ethnic minorities and underserved populations. Applications are invited to expand existing NCI-funded projects by incorporating a cancer disparities component, with a budget limit of $150,000 for a maximum of two years. Eligible applicants must hold active NCI awards that do not currently address cancer disparities. The initiative emphasizes research across various domains, including basic biology, prevention, treatment, and survivorship, particularly for cancers with documented health disparities. Key details include submission windows, requirements for electronic applications, and guidelines for collaboration. This effort supports the urgency to address cancer disparities and necessitates innovative approaches to existing research within the parameters of current funding mechanisms.
    Similar Opportunities
    Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)" aimed at investigating the biological and genetic mechanisms underlying cancer health disparities among diverse racial and ethnic populations. This funding initiative encourages innovative pilot studies that focus on identifying cancer risk factors, developing preventative strategies, and enhancing research methodologies, while fostering a multidisciplinary cohort dedicated to cancer health disparities research. Eligible applicants include a wide range of entities such as educational institutions, nonprofits, and tribal organizations, with a maximum funding amount of $275,000 available for a two-year project period. Interested parties should note that the application deadline is November 16, 2027, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-244.html for further details.
    Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Basic Research in Cancer Health Disparities grant, aimed at supporting innovative research into the biological and genetic causes of cancer health disparities among diverse racial and ethnic populations. This grant encourages applications from a wide range of eligible applicants, including higher education institutions, nonprofits, and organizations serving underrepresented groups, with a focus on mechanistic studies, new methodologies, and the use of biospecimens to uncover cancer risk factors and develop prevention strategies. The application process opens on January 5, 2025, with the first submission deadline on February 5, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-243.html.
    Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Supplements to Promote Diversity in Health-Related Research," aimed at enhancing diversity within the health research workforce. This initiative seeks to recruit and support individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and those from disadvantaged backgrounds, while providing necessary accommodations for researchers with disabilities. The funding, which can reach up to $500,000, is available for administrative supplements to existing research grants, with applications undergoing administrative review rather than peer review. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with the application deadline set for May 7, 2026.
    Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R01 Research Project Grant to enhance cancer screening and preventive services for populations experiencing health disparities. This initiative aims to address barriers to cancer care by developing interventions that operate at multiple levels, including patient, clinician, healthcare settings, and community factors, while encouraging collaboration with community partners. The funding reflects NIH's commitment to advancing health equity, particularly for historically underserved groups, and requires applicants to submit a Plan for Enhancing Diverse Perspectives. Interested applicants can find more information and guidelines at the provided link, with applications due by January 7, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE)" aimed at fostering collaborations between institutions serving underserved populations and NCI-designated Cancer Centers. The initiative seeks to enhance cancer research capacity, promote workforce diversity, and implement community outreach initiatives to address cancer health disparities. This program is vital for developing comprehensive research projects that include administrative cores, research education, and outreach efforts, ultimately contributing to a stronger national cancer program. Eligible applicants can request funding of up to $2.2 million over five years, with the application submission period starting on December 15, 2023. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Clinical Trial Optional mechanism, aimed at supporting exploratory and developmental research in cancer diagnosis, treatment, imaging, symptom management, and prevention. This grant is designed to encourage innovative studies that challenge existing paradigms and address critical barriers in cancer research, particularly focusing on reducing disparities among underserved populations. Eligible applicants include a wide range of organizations, such as historically black colleges, tribal governments, and faith-based organizations, with a maximum funding amount of $275,000 available over a two-year period. Interested parties can find more information and application details at the provided link, with a submission deadline of July 1, 2025, and inquiries directed to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities" (R01, Clinical Trial Required). This initiative aims to solicit applications for projects that identify and address barriers to cancer screening and preventive services, particularly in underserved populations, through multi-level interventions involving patients, clinicians, healthcare settings, and community partners. The focus is on developing evidence-based strategies to improve cancer outcomes for groups such as Black Americans, Hispanics, and Native Americans, emphasizing health equity and structured research methodologies. Interested applicants can find more details and submit proposals by January 7, 2027, with the first application due date being October 5, 2023. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov, and further information is available at NIH Grants.
    Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the "Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research" (R21 Clinical Trial Not Allowed). This funding opportunity aims to enhance diversity among early-stage and junior investigators in cancer research, particularly from groups that are underrepresented in the biomedical, behavioral, clinical, and social sciences. The initiative encourages innovative studies in cancer biology, with a maximum funding amount of $275,000 available over a two-year period, and applications must demonstrate scientific merit and innovation. The application window opens on May 17, 2024, with the first awards expected to be made in June 2024; interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering Administrative Supplements to existing NIH grants and cooperative agreements to address unforeseen costs that arise within the scope of approved awards. This funding opportunity is designed for organizations holding eligible parent awards, allowing them to apply for additional support when costs increase or new research objectives emerge. The initiative underscores NIH's commitment to facilitating ongoing research by providing flexible funding options, although applicants should note that funding availability is not guaranteed and depends on appropriations and the merit of applications. Interested parties can find more information and submit inquiries to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV, with applications due by January 24, 2025.
    Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Transformative Research to Address Health Disparities and Advance Health Equity" initiative, aimed at funding innovative research that addresses social determinants of health (SDOH) to significantly reduce health disparities and promote equity among underserved populations. This cooperative agreement seeks projects that demonstrate a compelling potential to produce major impacts on health equity, with a maximum funding amount of $500,000 per year for a project duration of up to five years, and a total funding commitment of approximately $3 million for 4-6 awards. Applications must include a Plan for Enhancing Diverse Perspectives (PEDP) and are expected to engage in community partnerships, with submission deadlines starting from January 29, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-NR-25-003.html.